Show advanced options

Select all Clear all

Story
Tease photo

The New Istituto Marangoni CEO is Female

For the first time in its 80 year history, a female Director will manage the entire Marangoni Group.

Starting November 2019, Stefania Valenti has been the new Managing Director of Istituto Marangoni succeeding Roberto Riccio, who guided the Group since 2009 through its brilliant phase of international growth. Throughout her remarkable work career, we have seen Valenti in roles at La Perla as Executive Vice President and Board Member, at MSGM undertaking the position of General Manager or joining Les Hommes Group where she served as Chief Executive Office and General Manager.

Story
Tease photo

Adding tucatinib to drug combination extends survival for advanced HER2+ breast cancer patients

Treatment showed significant benefit for patients with and without brain metastasis

Researchers from The University of Texas MD Anderson Cancer Center today reported study results showing the addition of tucatinib to capecitabine (Xeloda) and trastuzumab (Herceptin) significantly improved progression-free survival (PFS) and overall survival (OS) in patients with advanced HER2-positive breast cancer, with and without brain metastasis according to results of the HER2CLIMB clinical trial.

Story

Congressman Al Green and Representatives from the Greater Houston Area Commemorate Houston Methodist’s Centennial

On Wednesday, December 11, 2019, Congressman Al Green and Members of the Greater Houston delegation filed a congressional resolution in observation of Houston Methodist Hospital’s 100th anniversary. Congressman Green released the following statement:

Story

Lawyers’ Committee for Civil Rights Under Law Files Intervention on Behalf of Students to Defend Diversity and Promote Inclusive Access at UT-Austin

Today, the national Lawyers’ Committee for Civil Rights Under Law (Lawyers’ Committee) and pro bono counsel, Hunton Andrews Kurth, LLP, and Bernabei & Kabat, PLLC, filed a petition in State District Court of Travis County, Texas to intervene in a lawsuit brought by Ed Blum and his anti-affirmative action group, Students for Fair Admissions (SFFA), against the University of Texas at Austin (UT-Austin) (SFFA v. UT-Austin). Filed on May 16, 2019—on the eve of the 65th anniversary of Brown v. Board—this latest attack follows two prior, failed challenges by Blum in both federal and state courts to eliminate UT-Austin’s individualized consideration of race in its admissions program.

Story

Brightway Insurance welcomes new Independent Agents

More consumers now have the opportunity to enjoy a better way to shop for insurance as three insurance sales professionals are now on the path to the American dream of business ownership through the Brightway Insurance Independent Agent program. The Independent Agent program is a six- to 12-month period in which insurance sales professionals can qualify for a fully financed franchise fee to enter our Office Agent franchise program.

Story
Tease photo

"Kids & Christmas" Pops Concert

Saturday, December 21, 5:00pm Alice Pratt Brown Hall, Rice University

The Houston Children’s Chorus presents this annual family concert of holiday favorites accompanied by orchestra in the beautiful setting of Stude Concert Hall.

Story

AIDS Foundation Houston raises more than $150,000 at World AIDS Day Luncheon 2019

AIDS Foundation Houston, Inc. (AFH) hosted the annual World AIDS Day Luncheon on Friday, December 6, 2019, at The Ballroom at Bayou Place. Luncheon chairs Carrie Brandsberg-Dahl, Adrian Dueñas and Duyen Nguyen, with presenting sponsor Chevron, welcomed more than 500 guests to the annual fundraiser.

Story
Tease photo

Combination therapy results in 98% response rate for some newly diagnosed leukemia patients

Lower-dose chemotherapy plus monoclonal antibodies highly effective for older patients with newly diagnosed Philadelphia chromosome-negative acute lymphoblastic leukemia

A study led by The University of Texas MD Anderson Cancer Center showed that treatment combining lower doses of chemotherapy with the monoclonal antibody inotuzumab ozogamicin (INO), with or without the drug blinatumomab, is safe and effective in patients over 60 years of age who were newly diagnosed with a high-risk form of acute lymphoblastic leukemia (ALL) known as Philadelphia chromosome-negative ALL.

Story

Congresswoman Sheila Jackson Lee Statement Following Today’s Hearings of the House Judiciary Committee in the Impeachment Investigation of the President of the United States

Congresswoman Sheila Jackson Lee, a Senior Member of the House Committees on Judiciary, Homeland Security, and Budget, issued this statement following today’s hearing where the Judiciary Committee received evidence in the impeachment investigation of the President of the United States:

Story

Has A Betrayal Stolen Your Holiday Spirit?

How To Take Steps Toward Healing

The “most wonderful time of the year” doesn’t quite live up to its billing for anyone whose holiday itinerary includes healing psychological wounds after being betrayed by a spouse, friend or someone else close to them.

Story

Congresswoman Sheila Jackson Lee Statement Following the Release of the Report of the Inspector General of the Justice Department on the Origins of Operation Crossfire Hurricane

Congresswoman Sheila Jackson Lee, a Senior Member of the House Committees on Judiciary, Homeland Security, and Budget, issued this statement following the release of a report by the Inspector General of the Department of Justice concerning the origins of Operation Crossfire Hurricane:

Story

CAR T-cell therapy effective for relapsed mantle cell lymphoma patients

A one-year follow-up study led by The University of Texas MD Anderson Cancer Center revealed a majority of patients with mantle cell lymphoma resistant to prior therapies may benefit from treatment with CD19-targeting chimeric antigen receptor (CAR) T-cell therapy. Findings were presented Dec. 9 at the 61st American Society of Hematology Annual Meeting & Exposition in Orlando, Fla.

Story

Combination therapy more effective than chemotherapy alone for many newly diagnosed leukemia patients

Enasidenib plus azaticidine significantly improves complete remission and overall response for patients with acute myeloid leukemia tied to IDH2 mutations

A multi-institutional, Phase II study led by The University of Texas MD Anderson Cancer Center showed that pairing standard chemotherapy azacitidine (AZA) with a drug called enasidenib (ENA) measurably boosts complete remission in patients newly diagnosed with a specific form of acute myeloid leukemia (AML).

Story
Tease photo

Statement on Commissioner Steve Radack's Decision Not to Run for Reelection

It’s the beginning of a new era in Harris County. After 30 years in office, Commissioner Steve Radack has decided not to run for reelection. That leaves an open seat for Harris County Commissioner in Precinct 3.

Story

2020 U.S. Olympic Team Trials for Boxing Kicks Off in Exciting Fashion

The first day of competition at the 2020 U.S. Olympic Team Trials for Boxing was filled with impressive upsets and jaw-dropping knockdowns. The stage is set for some interesting matchups tomorrow; here’s how those boxers made their way to the next round.

Story

Local Employers Scramble to Keep Their Office Flu-Free

The US Centers for Disease Control and Prevention is sounding the alarm as the 2019–2020 flu season is escalating FAST.

Story

New Study Takes an Unprecedented Look at Being Black in Corporate America Despite billions spent on diversity and inclusion, new research from the Center for Talent Innovation finds that black profes

Corporate America needs to awaken to the challenges faced by black professionals, according to a new study published today by nonprofit think tank the Center for Talent Innovation (CTI).

Story

Art Colony Association Announces Bayou City Art Festival Memorial Park Featured Artist: McKenzie Fisk

Friday-Sunday, March 27-29, 2020

The Art Colony Association, Inc. (ACA) has announced the Bayou City Art Festival Memorial Park 2020 featured artist is McKenzie Fisk, a painter from Los Angeles. Fisk, along with 300 artists from around the country representing 19 different difference disciplines, will showcase their art at Bayou City Art Festival Memorial Park. The festival benefits Houston nonprofits, and will be held on Friday-Sunday, March 27-29, 2020.

Story

The Human Rights Campaign Endorses Houston Mayor Sylvester Turner for Re-Election

Today, the Human Rights Campaign (HRC), the nation’s largest lesbian, gay, bisexual, transgender and queer (LGBTQ) civil rights organization announced its endorsement of Houston Mayor Sylvester Turner’s bid for re-election.

Story

Why businesses need to rethink diversity training

It's not a one-size-fits-all solution, according to new research from Rice University

Within the past couple of years, Starbucks and Sephora have come under fire for racial insensitivity. They responded to the criticism and negative publicity by closing their stores for companywide diversity training.